Main > > >NAUSEA. *

Nausea and Vomiting. TREAT.:
Dronabinol Capsules. Generic.
USA Approval Date: 2018. 05.21.
(*) Company: Lannett Company Inc.
www.lannett.com
UpDate: 2018. 05.22.




Nausea and Vomiting. TREAT.:
Fosaprepitant for Injection. Generic.
USA Launch Date: 2019. 09.11.
(*) Company: Dr. Reddy s Laboratories
Ltd.
UpDate: 2020. 01.12.




Nausea and Vomiting. TREAT.:
Fosaprepitant for Injection 150 mg per Vial. Generic.
USA Launch Date: 2019. 11.13.
(*) Company: Fresenius Kabi.
UpDate: 2019. 12.02.




Nausea and Vomiting. TREAT.: Prochlor-
perazine Edisylate Inj. Generic.
USA Approval Date: 2019. 02.21.
(*) Company : Nexus Pharmaceuticals
Web-Site: www.nexuspharma.net
UpDate: 2019. 02.22.




Onco.>CT>Induced Nausea & Vomiting
Treat.: Aprepitant Capsules; for Oral
Suspension. (U)
(*) Company; Patent; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 09.23.




Onco.>CT>Induced Nausea & Vomoting
Treat.: Aprepitant Inj. Emulsion. (U)
USA Approval Date: 2017. 11.09.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 09.23.




Onco.>CT>Induced Nausea & Vomiting
Treat.: Cannabinoid Dronabinol Oral Solution CII.
Version of TetraHydroCannabinol.
USA Approval Date: 2016. 07.05.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 09.23.




Onco.>CT>Induced Nausea & Vomiting
Treat.: Extended Release Granisetron Inj. (U)
USA Approval Date: 2016. 08.10.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 09.23.




Onco.>CT>Induced Nausea & Vomiting Treat.: Granisetron Inj.
(*) Company : Roche
Patent : Expired 2007. 12.29.
TradeMark: Kytril
UpDate: 2018. 09.18.




Onco.>CT>Induced Nausea & Vomiting.
Treat.: Granisetron TransDermal System.
(J)
USA Approval Date: 2008. 09.12.
(*) Company; Patent; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 09.18.




Onco.>CT>Induced Nausea & Vomiting.
Treat.: Netupitant+Palonosetron Cap. (C)
EU Approval Date: 2015. 05.27.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 09.18.




Onco.>CT>Induced Nausea & Vomiting. Treat.: Palonosetron.HCl Inj. (C)
EU Approval Date : 2015. 05.27.
USA Approval Date: 2003. 07.25.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 09.18.




Onco.>CT>Induced Nausea & Vomiting. Treat.: Palonosetron.HCl Inj. (I)
Generics.
USA Launch Date: 2018. 03.23.
(*) Company Available on Request.
UpDate: 2018. 09.18.




Onco.>CT>Induced Nausea & Vomiting. Treat.: Palonosetron.HCl Inj. (K)
(*) Company; Patent & Web-Site Availa-
lable on Request.
UpDate: 2018. 09.21.




Onco.>CT>Induced Nausea & Vomiting. Treat.: Rolapitant.
- IV Form:
USA Approval Date: 2017. 10.25
USA Launch Date : 2017. 11.28
- Tablet Form:
EU Approval Date : 2017. 04.26
USA Approval Date: 2015. 09.01
NeuroKinin-1 Receptor AntAgonist
(*) Company; Patents; TradeMarks & Web-
Site Available on Request.
UpDate: 2018. 09.23.


>NAUSEA. *'s products
This section has no products